BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh AV, Khare M, Gade WN, Zamboni P. Theranostic implications of nanotechnology in multiple sclerosis: a future perspective. Autoimmune Dis 2012;2012:160830. [PMID: 23346386 DOI: 10.1155/2012/160830] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Singh R, Karakoti AS, Self W, Seal S, Singh S. Redox-Sensitive Cerium Oxide Nanoparticles Protect Human Keratinocytes from Oxidative Stress Induced by Glutathione Depletion. Langmuir 2016;32:12202-11. [PMID: 27792880 DOI: 10.1021/acs.langmuir.6b03022] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 9.3] [Reference Citation Analysis]
2 Zeng Y, Li Z, Zhu H, Gu Z, Zhang H, Luo K. Recent Advances in Nanomedicines for Multiple Sclerosis Therapy. ACS Appl Bio Mater 2020;3:6571-97. [DOI: 10.1021/acsabm.0c00953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Singh AV. Biotechnological applications of supersonic cluster beam-deposited nanostructured thin films: Bottom-up engineering to optimize cell-protein-surface interactions: Bottom-up Engineering to Optimize Cell-Protein-Surface Interactions. J Biomed Mater Res 2013;101:2994-3008. [DOI: 10.1002/jbm.a.34601] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
4 Sheykhansari S, Kozielski K, Bill J, Sitti M, Gemmati D, Zamboni P, Singh AV. Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review. Cell Death Dis 2018;9:348. [PMID: 29497049 DOI: 10.1038/s41419-018-0379-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 13.3] [Reference Citation Analysis]
5 Surana M, Singh Y, Lang DH. Fragility analysis of hillside buildings designed for modern seismic design codes. Struct Design Tall Spec Build 2018;27:e1500. [DOI: 10.1002/tal.1500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
6 Naqvi S, Panghal A, Flora SJS. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs. Front Neurosci 2020;14:494. [PMID: 32581676 DOI: 10.3389/fnins.2020.00494] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
7 Kevadiya BD, Ottemann BM, Thomas MB, Mukadam I, Nigam S, McMillan J, Gorantla S, Bronich TK, Edagwa B, Gendelman HE. Neurotheranostics as personalized medicines. Adv Drug Deliv Rev 2019;148:252-89. [PMID: 30421721 DOI: 10.1016/j.addr.2018.10.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
8 Latronico T, Depalo N, Valente G, Fanizza E, Laquintana V, Denora N, Fasano A, Striccoli M, Colella M, Agostiano A, Curri ML, Liuzzi GM. Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes. PLoS One 2016;11:e0153451. [PMID: 27097043 DOI: 10.1371/journal.pone.0153451] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
9 Yildiz T, Gu R, Zauscher S, Betancourt T. Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer. Int J Nanomedicine 2018;13:6961-86. [PMID: 30464453 DOI: 10.2147/IJN.S174068] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
10 Hassan S, Prakash G, Ozturk A, Saghazadeh S, Sohail MF, Seo J, Dockmeci M, Zhang YS, Khademhosseini A. Evolution and Clinical Translation of Drug Delivery Nanomaterials. Nano Today 2017;15:91-106. [PMID: 29225665 DOI: 10.1016/j.nantod.2017.06.008] [Cited by in Crossref: 116] [Cited by in F6Publishing: 94] [Article Influence: 23.2] [Reference Citation Analysis]